IS RESISTIN A LINK BETWEEN HIGHLY ACTIVE ANTIRETROVIRAL THERAPY AND FAT REDISTRIBUTION IN HIV-INFECTED CHILDREN?

Autor: Raffaele Iorio, Monica Volpicelli, Eugenia Bruzzese, Annunziata Officioso, Maria Immacolata Spagnuolo, G. De Marco, A. Franzese, N. Fasano, Gianfranco Vallone, Alfredo Guarino, Giuliana Valerio
Přispěvatelé: Spagnuolo, MARIA IMMACOLATA, Bruzzese, Eugenia, Vallone, Gianfranco, Fasano, N, De Marco, G, Officioso, Annunziata, Valerio, G, Volpicelli, M, Iorio, Raffaele, Guarino, Alfredo
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Zdroj: Scopus-Elsevier
Popis: OBJECTIVES: To assess the features of fat redistribution, detected by clinical and ultrasound (US) methods, and the presence of metabolic disorders in HIV-infected children undergoing antiretroviral therapy. To evaluate if serum levels of resistin, a hormone produced only by visceral adipose tissue, are a marker of fat redistribution in these patients. DESIGN AND METHODS: Forty-five consecutive symptomatic HIV-infected children were considered for inclusion in the study. Patients were enrolled if treated for at least 6 months with antiretroviral therapy with or without protease inhibitor (PI) and if compliant to the study protocol. Patients were evaluated for: anthropometric measures, fat redistribution by clinical and US methods, serum lipids, parameters of insulin resistance by homeostasis model assessment for insulin resistance, serum resistin levels by an enzyme-linked immunosorbent assay. RESULTS: Eighteen children fulfilled the inclusion criteria and were enrolled in the study. Twelve (66%) children had clinical and/or US evidence of fat redistribution; 9 (75%) of them were on PI therapy; only 3 of 6 children without fat redistribution were on PI therapy (p
Databáze: OpenAIRE